Drug approval (and rejection) highlights from 2012
Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines. Read more
Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines. Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research